PharmaVision offers a comprehensive choice of high quality, insightful reports which identify key trends, future innovations, and growth opportunities. Our reports cover the life science arena including pharmaceuticals, healthcare, diagnostics, drug delivery, emerging R&D technologies and consumer nutrition.
Immuno-oncology (IO) in the context of this report encompasses drug candidates which, either alone or in combination, act primarily through modulation of tumour immunity to restore or enhance an effective host immune response. This report sample is provided for the purpose of review and may be freely distributed provided authorship is acknowledged
